Correlation Between Anheuser Busch and Arcadia Biosciences

Can any of the company-specific risk be diversified away by investing in both Anheuser Busch and Arcadia Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anheuser Busch and Arcadia Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anheuser Busch Inbev and Arcadia Biosciences, you can compare the effects of market volatilities on Anheuser Busch and Arcadia Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anheuser Busch with a short position of Arcadia Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anheuser Busch and Arcadia Biosciences.

Diversification Opportunities for Anheuser Busch and Arcadia Biosciences

-0.41

Correlation Coefficient

Anheuser Busch  Arcadia Biosciences

Very good diversification

The 3 months correlation between Anheuser and Arcadia is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Anheuser Busch Inbev and Arcadia Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcadia Biosciences and Anheuser Busch is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anheuser Busch Inbev are associated (or correlated) with Arcadia Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcadia Biosciences has no effect on the direction of Anheuser Busch i.e., Anheuser Busch and Arcadia Biosciences go up and down completely randomly.

Pair Corralation between Anheuser Busch and Arcadia Biosciences

Considering the 90-day investment horizon Anheuser Busch Inbev is expected to under-perform the Arcadia Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Anheuser Busch Inbev is 11.36 times less risky than Arcadia Biosciences. The stock trades about -0.23 of its potential returns per unit of risk. The Arcadia Biosciences is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  289.00  in Arcadia Biosciences on September 15, 2024 and sell it today you would earn a total of  341.00  from holding Arcadia Biosciences or generate 117.99% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Anheuser Busch Inbev  vs.  Arcadia Biosciences

Anheuser Busch Inbev

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anheuser Busch Inbev has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Arcadia Biosciences

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Arcadia Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile fundamental indicators, Arcadia Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Anheuser Busch and Arcadia Biosciences

The main advantage of trading using opposite Anheuser Busch and Arcadia Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anheuser Busch position performs unexpectedly, Arcadia Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcadia Biosciences will offset losses from the drop in Arcadia Biosciences' long position.

The idea behind Anheuser Busch Inbev and Arcadia Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.